专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

EP0174770B1 Leukotriene antagonists, their preparation, use pharmaceutical compositions containing them and methods of making them 失效
标题翻译：紫外线拮抗剂，其制备，使用含有它们的药物组合物及其制备方法
公开(公告)号：EP0174770B1
公开(公告)日：1990-10-24
申请号：EP85306077.0
申请日：1985-08-27
申请人： MERCK FROSST CANADA INC.
发明人： Young, Robert N. , Rokach, Joshua
IPC分类号： C07D213/80 , C07D213/70 , C07D213/71 , C07D241/18 , C07D241/24 , C07D241/20 , A61K31/44 , A61K31/495
CPC分类号： C07D213/70 , C07D213/71 , C07D213/80

2. 发明公开

EP0301692A2 4,7-Benzofurandione derivatives 失效
标题翻译： 4,7- Benzofurandion衍。
公开(公告)号：EP0301692A2
公开(公告)日：1989-02-01
申请号：EP88305388.6
申请日：1988-06-13
申请人： MERCK FROSST CANADA INC.
发明人： Adams, Julian , Belanger, Patrice C. , Rokach, Joshua , Guindon, Yvan , Belly, Michel L.
IPC分类号： C07D307/06 , C07D407/06 , C07D407/04 , C07D407/12 , A61K31/34 , A61K31/36
CPC分类号： C07D407/06 , C07D307/86
摘要： 4,7-Benzofurandione derivatives of Formula I, pharmaceutical compositions, and methods of treatment are disclosed. These compounds are useful as inhibitors of mammalian leukotriene biosynthesis. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders, inflammation, psoriasis and allergic conjunctivitis. The compounds are also useful as analgesics and as cytoprotective agents. Also disclosed are novel intermediates useful for the preparation of the 4,7-benzofurandiones of this invention.
摘要翻译：公开了式I的4,7-苯并呋喃二酮衍生物，药物组合物和治疗方法。这些化合物可用作哺乳动物白三烯生物合成的抑制剂。因此，这些化合物是治疗过敏性疾病，哮喘，心血管疾病，炎症，牛皮癣和过敏性结膜炎的有用的治疗剂。这些化合物也可用作止痛剂和细胞保护剂。还公开了可用于制备本发明的4,7-苯并呋喃二酸的新型中间体。 v

3. 发明授权

EP0123543B1 Leukotriene antagonists, their production and use and compositions containing them 失效
标题翻译：白藜芦醇拮抗剂，其生产和使用及其组合物
公开(公告)号：EP0123543B1
公开(公告)日：1988-02-03
申请号：EP84302720.2
申请日：1984-04-19
申请人： MERCK FROSST CANADA INC.
发明人： Young, Robert N. , Williams, Haydn W. R. , Rokach, Joshua , Kakushima, Masatoshi , Guindon, Yvan
IPC分类号： C07C149/32 , C07C147/06 , C07C147/14 , C07C101/447 , C07D309/10 , C07D311/24 , C07D405/12
CPC分类号： C07C323/00 , A61K38/00 , C07C205/38 , C07D215/54 , C07D303/40 , C07D307/85 , C07D309/30 , C07D309/40 , C07D311/14 , C07D311/16 , C07D311/22 , C07D311/24 , C07D333/08 , C07D333/24 , C07D405/14 , C07D409/12 , C07F7/1856 , C07K5/0606

4. 发明公开

EP0140684A3 Leukotriene antagonists 失效
标题翻译：白三烯拮抗剂
公开(公告)号：EP0140684A3
公开(公告)日：1986-07-23
申请号：EP84307390
申请日：1984-10-26
申请人： MERCK FROSST CANADA INC.
发明人： Frenette, Richard , Rokach, Joshua , Young, Robert N. , Kakushima, Masatoshi
IPC分类号： C07C69/738 , C07C59/90 , C07D307/93 , C07C149/40 , C07C147/14 , A61K31/34 , A61K31/35 , A61K31/215 , C07C149/437
CPC分类号： C07D307/93 , C07C59/90 , C07C317/00 , C07C323/00
摘要： Compounds having the formula:
and their salts, including acid-addition salts, are novel. These compounds are antagonists of leukotrienes of C 4 , D 4 and E 4 , the slow reacting substance of anaphylaxis. The compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents and are made into suitable pharmaceutical compositions.
In the formula, each R, independently of the other(s), is H, OH or OR 2 , or C(R) 2 represents C=C(R 4 ) 2 ; R 1 is H, OH, acyl, formyl, R 5 CO; or R 5 OCO; each of R 2 and R 3 , independently of the others, is H, OH, C 1-6 alkyl, C 2-6 alkenyl, trifluoromethyl, C 1-6 alkoxy, SH, C 1-6 thioalkyl, phenyl, phenyl having C 1-3 alkyl halogen substitution, benzyl, phenethyl, halogen, amino, N(R 4 ) 2 , COOR 4 , CH 2 0R 4 , formyl, CN, trifluoromethylthio or nitro; .each of X 1 and X 2 , independently of the other, is oxygen, sulfur, sulfoxide, sulfone, -SO=NR 5 , NR e , N-CO-R 7 , N-CN or NCONHR 6 ; each of R 4 and R 6 , independently of the other(s), is H or C 1-6 alkyl; each R 5 is C 1-6 alkyl; each R 7 , independently of the other, if any, is C 1-6 alkyl or C 1-6 alkoxy; W is H or C 1-6 alkyl or is combined with Y to form an unsaturated bond; Z is H, OH or C 1-6 alkoxy, or is combined with Y to form an oxo residue; Y, of not combined with Z or W, is hydrogen; A is -[C(R 4 ) 2]s- R 8 where S is 0,1, 2, or 3 and R 8 isCOOR 4 , CH 2 0H, CHO, tetrazolyl, NHSO 2 R 9 , CONHSO 2 R 9 , hydroxymethylketone, CN, CON(R 7 ) 2 , a monocyclic heterocyclic ring containing an acidic hydroxyl group, or
where each s, independently, of the others, is 0, 1, 2 or 3 and R 10 is (A) a monocyclic or bicyclic radical containing from 3 to 12 nuclear carbon atoms and, as nuclear heteroatoms, two Ns or one N and one S, and with each ring in the heterocyclic radical being formed of 5 or 6 atoms, or (B) the radical X'-R 11 where X' is O, S or NH and R 11 contains up to 21 carbon atoms and is a hydrocarbon radical or an acryl radical of an organic acyclic or monocyclic carboxylic acid containing not more than 1 heteroatom in the ring; each n, independently of the others, is 0,1, or 3; R 9 is OH, C 1-6 alkyl, C 1-6 alkoxy, C 1-6 perfluoroalkyl, phenyl, or phenyl having one or more R 2 substituents.
摘要翻译：具有下式的化合物及其盐包括酸加成盐是新颖的。这些化合物是C4，D4和E4白三烯拮抗剂，即过敏反应的缓慢反应物质。这些化合物可用作抗哮喘剂，抗过敏剂，抗炎剂和细胞保护剂，并制成合适的药物组合物。在该式中，每个R独立于其它的一个或多个是H，OH或OR 2，或C（R）2表示C = C（R 4）2; R1是H，OH，酰基，甲酰基，R5CO; 或R5OCO; R2和R3各自独立地为H，OH，C1-6烷基，C2-6链烯基，三氟甲基，C1-6烷氧基，SH，C1-6硫代烷基，苯基，具有C1-3烷基卤素取代基的苯基，苄基，苯乙基，卤素，氨基，N（R 4）2，COOR 4，CH 2 OR 4，甲酰基，CN，三氟甲硫基或硝基; 每个X1和X2相互独立地为氧，硫，亚砜，砜，-SO = NR5，NRe，N-CO-R7，N-CN或NCONHR6; R 4和R 6中的每一个独立于另一个或多个，为H或C 1-6烷基; 每个R5是C1-6烷基; 如果有的话，每个R7独立于另一个是C1-6烷基或C1-6烷氧基; W是H或C 1-6烷基或与Y结合形成不饱和键; Z是H，OH或C 1-6烷氧基，或者与Y结合形成氧代残基; 未与Z或W结合的Y是氢; A是 - [C（R 4）2] s -R 8其中S是0,1,2或3且R 8是COOR 4，CH 2 OH，CHO，四唑基，NHSO 2 R 9，CONHSO 2 R 9，羟甲基酮，CN，CON（R 7）2，单环含有酸性羟基的杂环，或其中每一个独立地为其它的为0,1,2或3，且R 10为（A）含有3至12个核碳原子的单环或双环基团，并且作为核杂原子，两个N或一个N和一个S，并且杂环基团中的每个环由5或6个原子形成，或（B）基团X'-R11，其中X'是O，S或NH且R11含有至21个碳原子并且是环中含有不超过1个杂原子的有机无环或单环羧酸的烃基或丙烯酰基; 每个n彼此独立地为0,1或3; R9是OH，C1-6烷基，C1-6烷氧基，C1-6全氟烷基，苯基或具有一个或多个R2取代基的苯基。

5. 发明公开

EP0136893A3 Benzo[a]phenothiazines and hydro-derivatives and pharmaceutical compositions containing them 失效
标题翻译：苯并咪唑和水解衍生物及含有它们的药物组合物
公开(公告)号：EP0136893A3
公开(公告)日：1985-05-08
申请号：EP84306641
申请日：1984-09-28
申请人： MERCK FROSST CANADA INC.
发明人： Fortin, Rejean , Girard, Yves , Guindon, Yvan , Lau, Cheuk K. , Rokach, Joshua , Yoakim, Christiane
IPC分类号： A61K31/54 , A61K31/535 , C07D279/36 , C07D265/34 , C07F09/65
CPC分类号： C07F9/6547 , A61K31/535 , A61K31/54 , C07D265/34 , C07D279/36
摘要： Pharmaceutical compositions contain a compound for the Formula
or a pharmaceutically acceptable salt thereof. Certain compounds of Formula I are novel. Compounds of Formula I are useful in treating allergic conditions, asthma, cardrovascular disorders, inflammation and pain and are useful as cytoprotective agents.
In Formula 1. X is O, S, SO or SO 2 ; R, is H; C,- 6 alkyl; C, - 6 acyl; C 1-6 aminoacyl; (C 1-6 acyloxy)-(C 1-6 alkyl); (C 1-6 alkoxy)-(C l - 6 alkyl); benzoyl; substituted benzoyl in which the substitution in the phenyl ring (herein called "substituted as herein defined") is halogen, C 1-3 alkyl, C 1-3 alkoxy, CN, CF 3 , COOR 6 , OH, CH 2 COOR 6 or (CH 2 ) n NR 8 R 9 where n is 0, 1 or 2; carbamoyl; CONHR 7 ; COOR 7 ; p-toluenesulfonyl; methane sulfonyl; or an acyl group such that R,-OH is an essential amino acid; each of R 2 , R 3 , R 4 and R 5 , independently of the others, is hydrogen; C 1-6 alkyl; C 2-6 alkenyl; -(CHR 6 ) p COOR 6 , p being 0 or an integer from 1 to 4; or -(CH 2 ) m M where m is 0 or an integer from 1 to 6 and M is (a) OR, s ; (b) halogen; (c) CF 3 ; (d) SR 15 ; (e) phenyl or substituted phenyl as herein defined; (f) COOR 6 ; (g) CO-R 14 ; (h) tetrazolyl; (i) -NH-CO-R 7 ; (j) -NR 8 R 9 ; (k) -NHSO 2 R 10 where R 10 is OH, C 1-6 alkyl, C 1-6 alkoxy, or phenyl; (I) -COCH 2 0H; (m) -SOR 11 where R 11 is C 1-6 alkyl; phenyl; substituted phenyl as herein defined; (CH 2 ) m COOR 6 ;CN; formyl or C 1-4 perfluoroalkyl; (n) -CONR 8 R 9 ; (o) -SO 2 NR 8 R 9 ; (p) -SO 2 R 13 where R 13 is a hydrogen atom or a radical of the type defined for R 11 ; (q) NO 2 ; (r) O-CO-R 14 ; (s) O-CO-NR 8 R 9 ; (t) -CN; or (u) -OPO(OR 6 ) 2 : each R 6 , independently of any other, is H, phenyl or C 1-6 alkyl; each R 7 , independently of any other, is C 1-6 alkyl, benzyl, phenyl or (C 1-6 acyloxyl-(C 1-6 alkyl); each R 8 and each R 9 , independently of any other, is phenyl, substituted phenyl as herein defined, or C 1-4 alkyl, or NR 8 R 9 represents a heterocycloalkyl radical of 5 to 8 ring atoms; each R 14 , independently of any other, is H. (CH 2 ) p COOR 6 , C, 6 alkyl, C 1-6 alkoxy, (C 1-6 acyloxy)-(C 1-6 alkoxy), phenyl, substituted phenyl as herein defined, or C, -6 aminoalkyl, or R 14 is such that R 14 CO 2 H is an essential amino acid; R 15 is H, (C 1-6 alkoxy)-(C 1-6 alkyl), (C, 6 acyloxyl-(C 1-6 alkyl), C 1-6 alkyl, benzyl, -(CH 2 ) m COOR 6 , CN, formyl, C 1-4 perfluoroalkyl, CH 2 -R 12 where R 12 is C 1-5 alkyldimethylamino or phenyl, phenyl, or substituted phenyl as herein defined; the broken lines in ring A represent optional double bonds; R 2 , R 3 , R 4 and R 5 may be positioned anywhere in the structure.

6. 发明授权

EP0136893B1 Benzo[a]phenothiazines and hydro-derivatives and pharmaceutical compositions containing them 失效
标题翻译：苯并咪唑和水解衍生物和含有它们的药物组合物
公开(公告)号：EP0136893B1
公开(公告)日：1989-08-16
申请号：EP84306641.6
申请日：1984-09-28
申请人： MERCK FROSST CANADA INC.
发明人： Fortin, Rejean , Girard, Yves , Guindon, Yvan , Lau, Cheuk K. , Rokach, Joshua , Yoakim, Christiane
IPC分类号： A61K31/54 , A61K31/535 , C07D279/36 , C07D265/34 , C07F9/65
CPC分类号： C07F9/6547 , A61K31/535 , A61K31/54 , C07D265/34 , C07D279/36

7. 发明授权

EP0115394B1 Phenothiazone derivatives and analogs 失效
标题翻译：苯并噻唑衍生物和类似物
公开(公告)号：EP0115394B1
公开(公告)日：1989-06-28
申请号：EP84300239.5
申请日：1984-01-16
申请人： MERCK FROSST CANADA INC.
发明人： Guindon, Yvan , Fortin, Rejean , Lau, Cheuk K. , Rokach, Joshua , Yoakim, Christiane
IPC分类号： A61K31/54 , A61K31/535 , A61K31/495 , C07D279/18 , C07D265/38 , C07D241/46 , C07D293/10 , C07D279/34 , C07D279/36 , C07D265/34
CPC分类号： C07D293/10 , A61K31/495 , A61K31/535 , A61K31/54 , C07C46/06 , C07D241/46 , C07D265/34 , C07D265/38 , C07D279/18 , C07D279/34 , C07D279/36 , C07C50/28

8. 发明授权

EP0105692B1 6-H-dibenz(b,e)(1,4)oxathiepin derivatives and their preparation 失效
标题翻译： 6-H-DIBENZ（B，E）（1,4）氧化剂衍生物及其制备
公开(公告)号：EP0105692B1
公开(公告)日：1988-06-22
申请号：EP83305753.2
申请日：1983-09-27
申请人： MERCK FROSST CANADA INC.
发明人： Hamel, Pierre , Rokach, Joshua
IPC分类号： C07D327/02
CPC分类号： C07D327/02 , C07C323/00

9. 发明授权

EP0123541B1 Leukotriene antagonists 失效
公开(公告)号：EP0123541B1
公开(公告)日：1987-07-22
申请号：EP84302718.6
申请日：1984-04-19
申请人： MERCK FROSST CANADA INC.
发明人： Belanger, Patrice , Guindon, Yvan , Fortin, Rejean , Yaokim, Christiane , Rokach, Joshua
IPC分类号： C07C59/90 , C07C51/347 , C07C149/40 , C07C147/107 , C07D317/14 , C07D233/78 , C07D207/44 , C07D303/02 , A61K31/19
CPC分类号： C07D285/10 , C07C45/71 , C07C49/84 , C07C49/86 , C07C59/90 , C07C255/00 , C07D257/04

10. 发明公开

EP0165810A3 Benzofuran and benzothiophene derivatives, their use in inhibiting mammalian leukotriene biosynthesis, and pharmaceutical compositions containing these derivatives 失效
标题翻译：苯并呋喃和苯并噻吩衍生物，它们用于抑制MAMMALIAN LEUKOTRIENE BIOSYNESESIS，以及含有这些衍生物的药物组合物
公开(公告)号：EP0165810A3
公开(公告)日：1986-06-25
申请号：EP85304382
申请日：1985-06-19
申请人： MERCK FROSST CANADA INC.
发明人： Belanger, Patrice C. , Scheigetz, John , Rokach, Joshua
IPC分类号： C07D307/79 , C07D405/06 , C07D409/06 , C07D417/06 , C07D333/54 , A61K31/34 , A61K31/38 , A61K31/47 , A61K31/40 , A61K31/44 , A61K31/41
CPC分类号： C07D307/79 , C07D307/80 , C07D307/81 , C07D307/86 , C07D333/54 , C07D333/56 , C07D405/06 , C07D409/06 , C07D417/06 , C07D493/04 , C07F9/65517
摘要： Novel benzofuran compounds have the formula
in which
each R 1 is independently hydrogen or C 1 to C 6 alkyl; R 2 is hydrogen, C, to C 6 alkyl, -(CH 2 ) n -Het-Y, or
R 3 is hydroxyl,
OS0 3 H, or OP0 3 H 2 ; each R 4 is independently C 1 to C 6 alkyl; each R 5 is independently H, C, to C 6 alkyl, or both R 5 s join to form a 5- or 6-membered ring with the N to which they are attached; Het is a heterocyclic group selected from pyridine, pyrazine, pyrimidine, oxazole, pyrazole, oxadiazole, tetrazole, quinoline, thiophene, furan, pyrrole, thiazole, thiadiazole, or imidazole; X is O, S, SO, SO 2 ; Y, Y 1 , Y 2 , Y 3 , Y 4 and Z are each independently H, halogen, OH. C 1 to C 6 alkyl, C 2 to C 6 alkenyl, -COOR 1 , -COR 1 , nitro, C 1 to C 6 alkoxy, C 1 to C 6 alkylthio, -CH 2 SR 1 , OCH 2 CO 2 R 1 , and each n is independently 0 to 10; with the provisos that: (a) not all of R 1 , R 2 , Y, Y 1 , Y 2 , Y 3 , Y 4 , and Z are simultaneously H; (b) when up to 2 of R 1 , R 2 , Y, Y 1 , and Z are C 1 to C 2 alkyl, and the others of R 1 , R 2 , Y, Y', and Z are H, then R3 is not OH; and (c) when n in
is O and one of R 3 , Y, Y 1 or Z is OH, then R 1 is not H or C 1 to C 2 alkyl. Their pharmaceutically acceptable salts are also novel. These compounds are useful as inhibitors of mammalian leukotriene biosynthesis and are therefore useful therapeutic agents for treating allergic conditions, asthma, cardiovascu-Iar disorders, inflammation. The compounds are also useful as analgesics and as cytoprotective agents. They are made into pharmaceutical compositions for such uses.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式